Statins are effective cholesterol-lowering drugs for reducing the risks of mortality and
morbidity of cardiovascular diseases. Increasing evidence has shown that statin use is …

A high-intensity statin is recommended for the secondary prevention of cardiovascular
diseases (CVD). However, real-world evidence of the effectiveness of rosuvastatin following …

In recent years, the number of mathematical modelling studies has increased steeply. Many
of the questions addressed in these studies are relevant to the development of World Health …

Objectives: A high loading dose of atorvastatin has been confirmed to reduce
postprocedural events in patients undergoing percutaneous coronary intervention (PCI). In …

The performance of a drug in a clinical trial setting often does not reflect its effect in daily
clinical practice. In this third of three reviews, we examine the applications that have been …

Background: There has been concern that statin therapy may be associated with an
increased risk of intracerebral hemorrhage (ICH). We investigated whether the intensity and …

The aim of this study was to assess and compare the efficacy of atorvastatin with
rosuvastatin in preventing cardiovascular events among patients already diagnosed with …

Abstract We used the Archimedes Model, a mathematical simulation model (Model) to
estimate the clinical-and cost-effectiveness of using LDL particle concentration (LDL-P) as …

There is limited and inconsistent evidence for the association of statin therapy and statin
treatment patterns with the risk of recurrent intracerebral hemorrhage (ICH) in patients with …

Introduction Dipeptidyl peptidase-4 (DPP-4) inhibitors are a class of oral antidiabetic agents
for the treatment of type 2 diabetes mellitus, which lower blood glucose without causing …